Tedgui A - Search Results

1

Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis.

Rautou PE, Bresson J, Sainte-Marie Y, Vion AC, Paradis V, Renard JM, Devue C, Heymes C, Letteron P, Elkrief L, Lebrec D, Valla D, Tedgui A, Moreau R, Boulanger CM. Rautou PE, et al. Among authors: tedgui a. Gastroenterology. 2012 Jul;143(1):166-76.e6. doi: 10.1053/j.gastro.2012.03.040. Epub 2012 Mar 30. Gastroenterology. 2012. PMID: 22465620

2

Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis.

Soupison T, Yang S, Bernard C, Moreau R, Kirstetter P, D'Almeida M, Cailmail S, Tedgui A, Lebrec D. Soupison T, et al. Among authors: tedgui a. Clin Sci (Lond). 1996 Jul;91(1):29-33. doi: 10.1042/cs0910029. Clin Sci (Lond). 1996. PMID: 8774257

3

Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death.

Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Tedgui A. Mallat Z, et al. Among authors: tedgui a. Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):611-6. doi: 10.1161/01.atv.19.3.611. Arterioscler Thromb Vasc Biol. 1999. PMID: 10073964

4

Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques.

Tricot O, Mallat Z, Heymes C, Belmin J, Lesèche G, Tedgui A. Tricot O, et al. Among authors: tedgui a. Circulation. 2000 May 30;101(21):2450-3. doi: 10.1161/01.cir.101.21.2450. Circulation. 2000. PMID: 10831515

5

Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.

Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Boulanger CM, et al. Among authors: tedgui a. Circulation. 2001 Nov 27;104(22):2649-52. doi: 10.1161/hc4701.100516. Circulation. 2001. PMID: 11723013

6

Expression and regulation of the nuclear receptor RORalpha in human vascular cells.

Besnard S, Heymes C, Merval R, Rodriguez M, Galizzi JP, Boutin JA, Mariani J, Tedgui A. Besnard S, et al. Among authors: tedgui a. FEBS Lett. 2002 Jan 30;511(1-3):36-40. doi: 10.1016/s0014-5793(01)03275-6. FEBS Lett. 2002. PMID: 11821045 Free article.

7

Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure.

Mallat Z, Heymes C, Corbaz A, Logeart D, Alouani S, Cohen-Solal A, Seidler T, Hasenfuss G, Chvatchko Y, Shah AM, Tedgui A. Mallat Z, et al. Among authors: tedgui a. FASEB J. 2004 Nov;18(14):1752-4. doi: 10.1096/fj.04-2426fje. Epub 2004 Sep 15. FASEB J. 2004. PMID: 15371332

8

Dying for attention: microparticles and angiogenesis.

Boulanger CM, Tedgui A. Boulanger CM, et al. Among authors: tedgui a. Cardiovasc Res. 2005 Jul 1;67(1):1-3. doi: 10.1016/j.cardiores.2005.05.001. Cardiovasc Res. 2005. PMID: 15904903 No abstract available.

9

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM. Amabile N, et al. Among authors: tedgui a. J Am Soc Nephrol. 2005 Nov;16(11):3381-8. doi: 10.1681/ASN.2005050535. Epub 2005 Sep 28. J Am Soc Nephrol. 2005. PMID: 16192427

10

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

Boulanger CM, Amabile N, Tedgui A. Boulanger CM, et al. Among authors: tedgui a. Hypertension. 2006 Aug;48(2):180-6. doi: 10.1161/01.HYP.0000231507.00962.b5. Epub 2006 Jun 26. Hypertension. 2006. PMID: 16801490 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page